David Young

6PUBLICATIONS
16CO-AUTHORS
Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2026
Real-World Effectiveness, Safety and Quality of Life With Ustekinumab for the Treatment of Crohn's Disease: Results of the UK Ustekinumab Real World Evidence Study (UndieS) Study Group.

|Feb 07, 2025
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres.

David Young, Sohail Rahmany, Deborah Taylor

|Nov 27, 2024
Exploring Antibacterial Usage and Pathogen Surveillance over Five Years in a Tertiary Referral Teaching Hospital Adult General Intensive Care Unit (ICU).

David Young, Cathrine A McKenzie, Sanjay Gupta

|May 11, 2024
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS).

David Young, Clare Harris, Sohail Rahmany

|Jul 19, 2022
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn's disease: an interview study.

David Young, Fraser Cummings, Susan Latter

|Dec 17, 2021
Current evidence on the use of the adalimumab biosimilar SB5 (ImraldiTM): a multidisciplinary perspective.

Javier P Gisbert, Karl Gaffney, David Young

Pageof 1

Frequent Collaborators

3 joint publications

J R Fraser Cummings

2 joint publications

Susan Latter

1 joint publications

Javier P Gisbert

1 joint publications

Karl Gaffney